A study to compare the effectiveness and safety of bempedoic acid and ezetimibe for treating high lipid levels
Phase 4
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2024/07/070838
- Lead Sponsor
- Afzal Noor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Stable atherosclerotic cardiovascular disease
Uncontrolled LDL cholesterol level (fasting more than 70 mg/dl) on maximally tolerated dose of statin.(Atrovastatin 80 mg OD, Rosuvastatin 40 mg OD)
Exclusion Criteria
Age less than 18 yr
BMI more or equal 40 kg/m sq.
Triglyceride levels more or equal to 500 mg/dl
History of statin intolerance
History of cardiac event in last 12 weeks
Pregnant and Lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method